White Rose Optical Westgate Limited

White Rose Optical Westgate Ltd, based in Wakefield, UK, is a small, active company founded eleven years ago in 2014. It currently employs five people and holds £78,659 in assets. Despite its real address and two directors, the company is overdue on both accounts and confirmation statements for three years. Google users rate it 4.0 stars based on 32 reviews. It’s an irregular importer of electrical machinery and equipment, with just two months of import activity recorded.

The company operates as an independent optician, offering a range of services and products via its two branches in Castleford and Wakefield. Its website highlights a focus on unbeatable value, offering buy-one-get-one-free spectacles and one-hour turnaround for single vision glasses. It also boasts a wide selection of frames and lenses, catering to various needs and budgets. Customer testimonials praise the friendly service and competitive pricing, with one customer even getting prescription lenses put in sunglasses for a third of the price they were quoted elsewhere.

Financially, White Rose Optical Westgate Ltd’s picture is mixed. Current assets have increased by 7.5% to £79,000, while net assets have dropped by 61% to -£170,000. Bank borrowings have decreased by 19% to £61,000, and cash reserves have increased by 14% to £3,600. Creditors have decreased by 19% to £61,000. The company meets the criteria for a small company, with turnover under £10.2 million, assets under £5.1 million, and fewer than 50 employees. The significant drop in equity, however, suggests potential financial pressures. With no auditor mentioned, the figures are unaudited.

Overall, White Rose Optical Westgate Ltd appears to be navigating a challenging financial landscape, despite its positive customer reviews and strong local presence.

Registered in England/Wales under the registration number 08830120, with a registered address at WF1 1JZ, Wakefield, 11 Westgate.

WARNING:The numbers have been rounded for simplicity and may be inaccurate.Please, refer to the latest financial report for verification.